Your browser doesn't support javascript.
loading
[Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report].
Sakurai, T; Oura, S; Yoshimasu, T; Tanino, H; Kokawa, Y; Nakamura, T; Matsuyama, K; Naito, Y.
Affiliation
  • Sakurai T; First Dept. of Surgery, Wakayama Medical University.
Gan To Kagaku Ryoho ; 28(5): 707-10, 2001 May.
Article in Ja | MEDLINE | ID: mdl-11383223
ABSTRACT
A 56-year-old male patient underwent a right upper lobectomy and lymph node dissection for non-small cell lung cancer in March 1994. Multiple lung metastases in the right lung were found 45 months after the operation, and chemotherapy with docetaxel was administered. A liver metastasis was detected 11 months later, and it was refractory to docetaxel. Therefore, the patient was treated with cisplatin, mitomycin C and vinorelbine, which resulted in no change to the liver metastasis. He was next treated with gemcitabine, which resulted in a partial response of the liver metastasis. The adverse effects of gemcitabine were Grade 3 thrombocytopenia and Grade 2 neutropenia. The response duration for gemcitabine therapy was three months.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Deoxycytidine / Liver Neoplasms / Lung Neoplasms / Antimetabolites, Antineoplastic Limits: Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2001 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Deoxycytidine / Liver Neoplasms / Lung Neoplasms / Antimetabolites, Antineoplastic Limits: Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2001 Document type: Article